7 unknown. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 7 |
| Phase 2 | 1 | Unknown 1 |
Follow Chorea: new trials by email Literature Review of Chorea trials Research Report on Chorea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Symptomatic Therapy for Patients With Huntington's Disease Haloperidol 2Mg Tab, Risperidone 1Mg Tab, Zoloft 50Mg Tablet - Huntington Disease | Phase 1 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 60 | 2020-03-12 | 2021-04-02 |
| Nilotinib in Huntington's Disease Nilotinib 150 MG - Huntington Disease | Phase 1 | Unknown | Georgetown University | 10 | 2018-11-15 | 2020-02-20 |
| CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects CKD-504, Placebo - Huntington Disease | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 88 | 2018-05-23 | 2020-02-24 |
| Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease Cellavita HD Lower Dose, Cellavita HD Higher dose - Huntington Disease | Phase 1 | Unknown | Azidus Brasil | 6 | 2017-10-16 | 2022-11-02 |
| Safety and Efficacy of Bone Marrow Derived MNCs for Treatment of Cells for the Treatment of Hunting Tons Chorea. autologous Stem Cell - Huntington Disease | Phase 1 / Phase 2 | Unknown | Chaitanya Hospital, Pune | 50 | 2014-09-01 | 2014-09-17 |
| Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD) Far Infrared Radiation - Huntington Disease | Phase 1 | Unknown | GAAD Medical Research Institute Inc. | 5 | 2008-05-01 | 2009-01-05 |
| Ursodiol in Huntington's Disease ursodiol, placebo - Huntington Disease | Phase 1 | Unknown | Oregon Health and Science University | 21 | 2007-08-01 | 2009-02-05 |
Basal Ganglia Diseases (7) · Brain Diseases (7) · Central Nervous System Diseases (7) · Cognition Disorders (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Dementia (7) · Dyskinesias (7) · Genetic Diseases, Inborn (7) · Heredodegenerative Disorders, Nervous System (7) · Mental Disorders (7) · Movement Disorders (7) · Nervous System Diseases (7) · Neurocognitive Disorders (7) · Neurodegenerative Diseases (7)
CKD-504 (1) · Cell- and Tissue-Based Therapy (1) · Haloperidol (1) · Histone Deacetylase Inhibitors (1) · Risperidone (1) · Sertraline (1) · Tablets (1) · Ursodeoxycholic Acid (1) · deutetrabenazine (1) · idebenone (1) · nilotinib (1)
Azidus Brasil (1) · Chaitanya Hospital, Pune (1) · Chong Kun Dang Pharmaceutical (1) · GAAD Medical Research Institute Inc. (1) · Georgetown University (1) · Oregon Health and Science University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
United States (2) · Brazil (1) · Canada (1) · China (1) · India (1) · South Korea (1)
Joyce Macedo da Silva, MD (1) · Ken Nedd, M.D. (1) · Kyung-Sang Yu (1) · Penelope Hogarth, M.D. (1) · Zhi-Ying Wu (1)